http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1142544-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C319-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-44 |
| filingDate | 1980-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1983-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8d7bfc0075e08e30d740d2ff491bcc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_465623c2ffb98437d935066483626ce5 |
| publicationDate | 1983-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1142544-A |
| titleOfInvention | N-cyano-n'-(2-[(4-methyl-5-imidazolyl) methylthio]ethyl) - n"-alkynylguanidines h.sub.2 receptor blocking agents |
| abstract | ABSTRACT ABRIDGEMENT OF THE DISCLOSURE Histamine H2 receptor antagonists which inhibit gastric secretion in animals and are useful in the treatment of peptic ulcer disease having the formula I wherein R1 is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms, inclusive, non-toxic pharmaceutically acceptable acid addition salts thereof, intermediates therefore and processes for their production. |
| priorityDate | 1977-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.